查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1737256

全球医疗保健生物微机电系统 (BioMEMS) 和微系统市场 - 市场规模（按类型、应用、地区、预测）

Global BioMEMS And Microsystem In Healthcare Market Size By Type, By Application, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

医疗领域生物MEMS及微系统的市场规模及预测

2024 年医疗保健生物微机电系统和微系统市场规模价值 59 亿美元，预计到 2032 年将达到 137 亿美元，预测期内（2026-2032 年）的复合年增长率为 13.20%。

行动医疗应用需求的日益增长，以及有助于疾病早期诊断和降低死亡率的病患监测设备的市场发展，将在预测期内推动全球医疗生物微机电系统 (BioMEMS) 和微系统市场的发展。此外，生物微机电系统 (BioMEMS) 在建立全球健康应用方面的日益广泛应用，对于理解生物系统至关重要，而各种生物微机电系统 (BioMEMS) 应用的普及，很可能在未来一年推动全球市场的成长。 《全球医疗生物微机电系统 (BioMEMS) 和微系统市场报告》对市场进行了全面的评估，对关键细分市场、趋势、市场驱动因素、市场限制、竞争格局以及影响市场的关键因素进行了全面的分析。

定义医疗保健领域生物微机电系统 (BioMEMS) 和微系统的全球市场

具有生物或生物医学功能的MEMS称为BioMEMS。 MEMS是一种将生物分子作为关键组件的医疗设备。 医疗设备在医疗产业中用于监控压力、温度和运动，传输光学和电子数据，以及操控微型元件。

生物微机电系统 (BioMEMS) 是用于生物医学研究和医疗应用的微机电系统 (MEMS) 装置的子类型。生物微机电系统将微型感测器、致动器、微光学器件、微流体装置和结构组件与电脑和控制系统整合在一起。医疗产业的微系统用途广泛。这些装置能够提升医疗设备的效能，为医疗设备医疗设备製造商带来竞争优势。加速计利用 MEMS 和奈米技术改善了心臟治疗和药物传输。

BioMEMS 设备可植入人体特定部位，提供个人化药物治疗。药物传递系统可在药物注射体内时调节剂量，进而增强药物疗效，同时最大程度降低副作用风险。 BioMEMS 设备中的感测器利用特定的标记分子追踪药物的释放曲线和疗效。这些指标有助于医生了解所治疗疾病是否正在进展。加速计、陀螺仪、压力感测器、麦克风、超音波感测器、流量计、光学 MEMS/MOEMS、热电堆、气体感测器和微流体是 BioMEMS 的一些最常见应用。

医疗保健市场概览

预计全球医疗生物微机电系统 (BioMEMS) 和微系统市场将在预测期内取得显着发展。生物微机电系统和微系统在临床和生物应用中发挥着不可或缺的作用，它们能够监测一些最紧迫的健康相关问题，例如医疗成本和疾病预防技术。此外，生物微机电系统的出现为升级目前仅限于被动扩散装置的经皮给药系统提供了巨大的潜力，从而推动市场成长。此外，有助于检测疾病早期症状以降低死亡率的病患监测设备的发展也将进一步推动市场成长。

此外，医疗成本的不断上涨，也使得对相对实惠的健康监测设备的需求不断增长，这些设备可以取代传统的定期体检。感测器可以安装在家中的各个角落，监测日常活动并报告任何异常情况。这类感测器还可用于及时监测患者健康状况，提供准确可靠的数据，帮助评估患者的健康状况。这项技术有望惠及老年人群，使他们能够定期接受体检并获得及时支持。从而推动全球医疗领域生物微机电系统 (BioMEMS) 和微系统市场的成长。

此外，微技术的进步，加上基因组学、蛋白质组学和生物技术方法的最新趋势，为生物微机电系统 (BioMEMS) 设备应用开闢了全新且令人着迷的可能性。这些设备能够实现新的生物感测、分子识别和监测、药物传输、实验室晶片技术以及利用微技术建构的未来生物医学和生物系统。因此，这项技术进步将为全球生物微机电系统和微系统市场在医疗保健领域带来新的机会。然而，由于开发成本高以及产品开发週期长且难以被广泛接受，全球生物微机电系统和微系统市场预计将受到限制。

此外，对 BioMEMS 的认知度低将阻碍市场成长。

此外，突如其来的新冠肺炎疫情对全球产业造成了不利影响。生物微机电系统（MEMS）和微系统製造企业正在重新思考其长期策略，以期在疫情后提升竞争力。为了因应供应链中断、需求波动等一连串挑战，企业正在调整策略，调整产品系列组成、资本投入、研发策略、併购策略等。

目录

第一章：医疗健康领域生物MEMS与微系统的全球市场简介

  • 市场概览
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章全球生物MEMS与医疗微系统市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

第五章全球医疗保健领域生物MEMS和微系统市场（按类型）

  • 概述
  • 生物微机电系统
  • 微系统

第六章 医疗保健领域生物MEMS和微系统的全球市场（按应用）

  • 概述
  • 微流体
  • 用于药物输送的微型分配器
  • 低电平表
  • 其他的

第七章全球医疗生物MEMS和微系统市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 拉丁美洲
    • 中东和非洲

第八章全球医疗保健生物MEMS与微系统市场的竞争格局

  • 概述
  • 各公司市场排名
  • 主要发展策略

第九章 公司简介

  • Bluechiip
  • Cepheid
  • Given Imaging
  • Integrated Sensing
  • Boston Scientific
  • Becton Dickinson and Co（BD）
  • Heimann Sensor
  • CapitalBio
  • Lepu Medical Technology
  • Nanopass Technologies

第十章 附录

  • 相关调查
简介目录
Product Code: 59296

BioMEMS And Microsystem In Healthcare Market Size And Forecast

BioMEMS And Microsystem In Healthcare Market size was valued at USD 5.9 Billion in 2024 and is projected to reach USD 13.7 Billion by 2032, growing at a CAGR of 13.20 % during the forecast period 2026-2032.

The growing need for mobile care applications, and the development of patient monitoring equipment that aids in the early diagnosis of disease indications and therefore lowers mortality rates, will propel the global BioMEMS And Microsystem In Healthcare Market forward over the anticipated period. In addition, the expanding use of BioMEMS in creating global health & applications essential for understanding biological systems, and the availability of a wide range of BioMEMS applications, are likely to fuel global market growth over the coming year. The Global BioMEMS And Microsystem In Healthcare Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global BioMEMS And Microsystem In Healthcare Market Definition

MEMS with biological or biomedical functions are known as BioMEMS or biomedical microelectromechanical systems. MEMS are medical gadgets that incorporate live molecules as a critical component. MEMS are medical devices that include living molecules as an essential element of the device. Medical devices that contain biological molecules as an integral part of the device are known as MEMS. MEMS are utilized in the medical industry to monitor pressures, temperatures, and movement, transfer optical and electronic data carry fluids, and operate a micro-size component, among other functions.

BioMEMS is the subtype of MEMS devices utilized in biomedical research and medical applications. BioMEMS integrates microscopic sensors, actuators, micro-optics, microfluidics, and structural components with a computer and control system. Microsystems in the healthcare industry are used for various purposes. These devices increase the performance of medical equipment by giving medical device producers a competitive advantage. Accelerometers have improved cardiac disease treatment, as has the use of MEMS and nanotechnology to improve drug delivery.

The BioMEMS device can be implanted in a specific area of the body to administer personalized medication therapy. The delivery system takes over and regulates the dose when the medication is delivered into the body, enhancing the drug's effectiveness while minimizing the risk of side effects. The sensors in BioMEMS devices track the drug's release profile and effectiveness using specific marker molecules. These indicators can help doctors figure out if the disease they're treating has advanced. Accelerometers, gyroscopes, pressure, microphones, ultrasound, Flowmeters, Optical MEMS/MOEMS, Thermopiles, Gas sensors, and Microfluidics are some of the most common applications for BioMEMS.

Healthcare Market Overview

The global BioMEMS And Microsystem In Healthcare Market are expected to observe notable progress over the forecasted period. BioMEMS and microsystems play an essential role in clinical and biological applications by monitoring some of the most pressing health-related issues, such as healthcare costs and disease prevention techniques. Additionally, with the advent of BioMEMS devices, there is a massive potential for upgrading transdermal drug delivery systems, which are now confined to passive diffusion devices, resulting in market growth. Moreover, the development of patient monitoring equipment that helps in detecting early symptoms of diseases, to reduce the mortality rate will further propel the market growth.

Furthermore, the rising healthcare costs have necessitated the increase in demand for health monitoring equipment, which is a comparatively more affordable alternative to traditional routine check-ups. Sensors can be placed throughout a home to monitor daily activities and report on any odd changes. Sensors of this type are also used for monitoring unwell patients in a timely manner. It gives accurate and dependable data that aids in the assessment of one's health. This technology has the potential to benefit the elderly population by allowing them to receive frequent exams and prompt support. Thus, driving the growth of the global BioMEMS And Microsystem In Healthcare Market.

Also that, the advancement of microtechnology, combined with recent developments in genomics, proteomics, and biotechnology approaches, has opened up new and intriguing possibilities for BioMEMS device applications. These gadgets will enable new biosensing, molecular identification and monitoring, medication delivery, lab-on-a-chip technologies, and futuristic biomedical and biological systems using microtechnology. Thus, the Advancing Technologies will open up new opportunities for the global BioMEMS And Microsystem In Healthcare Market. However, the global BioMEMS And Microsystem In Healthcare Market are anticipated to be restrained by a lack of acceptance due to high development costs and extensive and long product development cycles.

Additionally, the lack of awareness about BioMEMS will hamper the growth of the market.

Furthermore, the unexpected emergence of covid 19 pandemics has a negative impact on the global industry. Companies that make BioMEMS and Microsystems are rethinking their long-term strategy in order to be more competitive in the aftermath of the COVID outbreak. Companies are revising their strategies in response to a slew of challenges, including supply chain disruptions, demand fluctuations, and other pressing concerns, by changing the composition of product portfolios, capital investment, Research & Development strategies, acquisitions & mergers, and other policies.

Global BioMEMS And Microsystem In Healthcare Market: Segmentation Analysis

The Global BioMEMS And Microsystem In Healthcare Market is Segmented on the basis of Type, Application, and Geography.

BioMEMS And Microsystem In Healthcare Market, By Type

  • BioMEMS
  • Microsystem

Based on Type, the BioMEMS And Microsystem In Healthcare Market is bifurcated into BioMEMS and Microsystem. The BioMEMS segment dominates the global market and is expected to grow further during the forecasted period owing to the rising use of BioMEMS in the healthcare industry. Also, the use of BioMEMS for patient care, patient monitoring, IVD scanning, medical imagining, drug delivery, and pharmaceutical research is contributing to the market growth.

BioMEMS And Microsystem In Healthcare Market, By Application

  • Microfluidics
  • Micro Dispensers for Drug Delivery
  • Low Meters
  • Others

Based on Application, the BioMEMS And Microsystem In Healthcare Market is bifurcated into Microfluidics, Micro Dispensers for Drug Delivery, Low Meters, and Others. The microfluidic segment dominates the global BioMEMS And Microsystem In Healthcare Market owing to the increased use of microfluidics in healthcare applications.

BioMEMS And Microsystem In Healthcare Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of regional analysis, the Global BioMEMS And Microsystem In Healthcare Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American region dominated the global BioMEMS And Microsystem In Healthcare Market in healthcare mainly due to the increasing demand for lifestyle products for health monitoring. In addition, the Asia Pacific region is expected to witness significant growth during the forecasted period, owing to the growing need for patient monitoring equipment for the early diagnosis of disease.

Key Players

The "Global BioMEMS And Microsystem In Healthcare Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Bluechiip, Cepheid, Given Imaging, Integrated Sensing, Boston Scientific, Becton Dickinson and Co (BD), Heimann Sensor, CapitalBio, Lepu Medical Technology, and Nanopass Technologies.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL BIOMEMS AND MICROSYSTEM IN HEALTHCARE MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL BIOMEMS AND MICROSYSTEM IN HEALTHCARE MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL BIOMEMS AND MICROSYSTEM IN HEALTHCARE MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 BioMEMS
  • 5.3 Microsystem

6 GLOBAL BIOMEMS AND MICROSYSTEM IN HEALTHCARE MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Microfluidics
  • 6.3 Micro Dispensers for Drug Delivery
  • 6.4 Low Meters
  • 6.5 Others

7 GLOBAL BIOMEMS AND MICROSYSTEM IN HEALTHCARE MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East and Africa

8 GLOBAL BIOMEMS AND MICROSYSTEM IN HEALTHCARE MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Bluechiip
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Cepheid
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Given Imaging
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Integrated Sensing
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Boston Scientific
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Becton Dickinson and Co (BD)
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Heimann Sensor
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 CapitalBio
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Lepu Medical Technology
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 Nanopass Technologies
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Appendix

  • 10.1 Related Research